21 U.S.C. § 1603
Verified against govinfo.gov as of June 20, 2026View official text on govinfo.gov ↗
- (a)
- (1)In any civil action covered by this chapter, a biomaterials supplier may—
- (2)Notwithstanding any other provision of law, a Federal or State court in which an action covered by this chapter is pending shall, in connection with a motion under section 1605 or 1606 of this title, use the procedures set forth in this chapter.
- (b)
- (1)Except as provided in paragraph (2), this chapter applies to any civil action brought by a claimant, whether in a Federal or State court, on the basis of any legal theory, for harm allegedly caused, directly or indirectly, by an implant.
- (2)A civil action brought by a purchaser of a medical device, purchased for use in providing professional health care services, for loss or damage to an implant or for commercial loss to the purchaser—
- (c)
- (1)This chapter supersedes any State law regarding recovery for harm caused by an implant and any rule of procedure applicable to a civil action to recover damages for such harm only to the extent that this chapter establishes a rule of law applicable to the recovery of such damages.
- (2)Any issue that arises under this chapter and that is not governed by a rule of law applicable to the recovery of damages described in paragraph (1) shall be governed by applicable Federal or State law.
- (d)Nothing in this chapter may be construed—
- (1)to affect any defense available to a defendant under any other provisions of Federal or State law in an action alleging harm caused by an implant; or
- (2)to create a cause of action or Federal court jurisdiction pursuant to section 1331 or 1337 of title 28 that otherwise would not exist under applicable Federal or State law.